News
NGS identification of both male and female cancer risks
Do you know a man who has participated at least once in “Movember”? Every year, thousands of men participate in this event to raise awareness
Thrombophilia an important factor in thrombosis risk
Every year world thrombosis day is held on October 13 to bring awareness to the potential risks of developing thrombisis. While thrombosis gets the most
Devyser products now available in Peru
Devyser is excited to announce a new partnership with Biotecnomica in Peru! Our products have now been used to improve laboratory workflows in over 60
Novel Somatic BRCA2 Variant Identified using the Devyser BRCA NGS kit.
In a case study published in Human Genome Variation (Costella et al. 2018), a novel somatic pathogenic variant of the BRCA2 gene was identified using
Easily identify BRCA1 and BRCA2 genetic mutations
With cancer identified as the leading cause of death in high-income countries, early identification and treatment of cancer, and potential cancer-causing genetic variants, is essential.
Looking for new colleagues in our R&D Team
Devyser is now searching for 2 new research scientists and a senior scientist to join our research and development team! Do you know a stellar
Cancer overtaking heart disease as leading cause of death
Cancer is overtaking heart disease as the leading cause of death, according to a study published recently in The Lancet medical journal. While heart disease
Devyser in Croatia
From Sweden to sunny Croatia – Devyser products are improving standardised testing in more than 50 countries around the world!
Devyser operating through the summer
It’s summer in Sweden, which means most people are on vacation, enjoying the weather and being outdoors as much as possible. Many businesses shut down